SGTX insider filings

Name: SGTX insider filings (SEC Forms 3/4/5)
Creator: FilingPulse
License: https://www.sec.gov/edgar

Sigilon Therapeutics, Inc. — 43 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-08-15. Screen SGTX transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for SGTX between 2026-07-29 and 2026-10-27. The table below lists the most recent filings on record.

Recent insider filings — Sigilon Therapeutics, Inc.

Filed	Form	Insider	Reported transactions	Source
2023-08-15	4	Flagship Ventures Fund V General Partner LLC — 10% owner Flagship Ventures Fund V, L.P. — 10% owner Flagship Pioneering Special Opportunities Fund II, L.P. — 10% owner Flagship Pioneering Special Opportunities Fund II General Partner LLC — 10% owner Flagship Pioneering Inc. — 10% owner AFEYAN NOUBAR — 10% owner	Code (U): 683,760 @ $14.92 · Code (U): 113,960 @ $14.92	EDGAR
2023-08-14	4	ELI LILLY & Co — 10% owner Shenandoah Acquisition Corp — 10% owner	Purchase (P): 1,718,493 @ $14.92	EDGAR
2023-08-11	4	Ashton-Rickardt Philip — CHIEF SCIENTIFIC OFFICER	Disposition to issuer (D): 8,845 (derivative) @ $0.75	EDGAR
2023-08-11	4	Yuan Qing Sarah — CTOO	Disposition to issuer (D): 2,884 · Disposition to issuer (D): 8,846 (derivative) @ $0.75	EDGAR
2023-08-11	4	Pontes Josias — CHIEF FINANCIAL OFFICER	Disposition to issuer (D): 3,504 · Disposition to issuer (D): 10,767 (derivative) @ $0.75	EDGAR
2023-08-11	4	Kowalsky Matthew Paul — CHIEF OF STAFF AND CLO	Disposition to issuer (D): 1,925 · Disposition to issuer (D): 12,690 (derivative) @ $0.75	EDGAR
2023-08-11	4	Patel Kavita — Director	Disposition to issuer (D): 683 (derivative) @ $6.64 · Disposition to issuer (D): 683 (derivative) @ $5.00	EDGAR
2023-08-11	4	Shaff Eric D. — Director	Disposition to issuer (D): 683 (derivative) @ $6.64 · Disposition to issuer (D): 683 (derivative) @ $5.00	EDGAR
2023-08-11	4	Vivaldi Coelho Rogerio — PRESIDENT AND CEO, Director	Disposition to issuer (D): 12,169 · Disposition to issuer (D): 35,382 (derivative) @ $0.75	EDGAR
2023-08-11	4	Cox John — Director	Disposition to issuer (D): 341 · Disposition to issuer (D): 683 (derivative) @ $6.64 · Disposition to issuer (D): 683 (derivative) @ $5.00	EDGAR
2023-08-11	4	Cole Douglas G. — Director	Disposition to issuer (D): 683 (derivative) @ $6.64 · Disposition to issuer (D): 683 (derivative) @ $5.00	EDGAR
2023-08-11	4	RUFFOLO ROBERT R — Director	Disposition to issuer (D): 683 (derivative) @ $6.64 · Disposition to issuer (D): 683 (derivative) @ $5.00 · Disposition to issuer (D): 3,754 (derivative) @ $7.51	EDGAR
2023-08-11	4	Oesterle Stephen N. — Director	Disposition to issuer (D): 683 (derivative) @ $6.64 · Disposition to issuer (D): 683 (derivative) @ $5.00 · Disposition to issuer (D): 4,273 (derivative) @ $7.51	EDGAR
2023-07-27	4	Yuan Qing Sarah — CTOO	Option exercise (M): 2,884 @ $19.24 · Option exercise (M): 2,884 (derivative) @ $0	EDGAR
2023-07-24	4	Pontes Josias — CHIEF FINANCIAL OFFICER	Option exercise (M): 1,444 @ $19.24 · Option exercise (M): 1,444 (derivative) @ $0	EDGAR
2023-07-24	4	Vivaldi Coelho Rogerio — PRESIDENT AND CEO, Director	Option exercise (M): 5,528 @ $19.24 · Option exercise (M): 5,528 (derivative) @ $0	EDGAR
2023-05-22	4	Patel Kavita — Director	Grant/award (A): 8,888 (derivative) @ $0	EDGAR
2023-05-22	4	Shaff Eric D. — Director	Grant/award (A): 8,888 (derivative) @ $0	EDGAR
2023-05-22	4	Cox John — Director	Grant/award (A): 8,888 (derivative) @ $0	EDGAR
2023-05-22	4	Cole Douglas G. — Director	Grant/award (A): 8,888 (derivative) @ $0	EDGAR
2023-05-22	4	RUFFOLO ROBERT R — Director	Grant/award (A): 8,888 (derivative) @ $0	EDGAR
2023-05-22	4	Oesterle Stephen N. — Director	Grant/award (A): 8,888 (derivative) @ $0	EDGAR
2023-03-01	4	Pontes Josias — CHIEF FINANCIAL OFFICER	Grant/award (A): 140,000 (derivative) @ $0	EDGAR
2023-03-01	4	Ashton-Rickardt Philip — CHIEF SCIENTIFIC OFFICER	Grant/award (A): 115,000 (derivative) @ $0	EDGAR
2023-03-01	4	Yuan Qing Sarah — CTOO	Grant/award (A): 115,000 (derivative) @ $0	EDGAR
2023-03-01	4	Kowalsky Matthew Paul — CHIEF OF STAFF AND CLO	Grant/award (A): 165,000 (derivative) @ $0	EDGAR
2023-03-01	4	Vivaldi Coelho Rogerio — PRESIDENT AND CEO, Director	Grant/award (A): 460,000 (derivative) @ $0	EDGAR
2022-05-27	4	Story Brooke — Director	Grant/award (A): 8,888 (derivative) @ $0	EDGAR
2022-05-27	4	Patel Kavita — Director	Grant/award (A): 8,888 (derivative) @ $0	EDGAR
2022-05-27	4	Shaff Eric D. — Director	Grant/award (A): 8,888 (derivative) @ $0	EDGAR
2022-05-27	4	Cox John — Director	Grant/award (A): 8,888 (derivative) @ $0	EDGAR
2022-05-27	4	Cole Douglas G. — Director	Grant/award (A): 8,888 (derivative) @ $0	EDGAR
2022-05-27	4	RUFFOLO ROBERT R — Director	Grant/award (A): 8,888 (derivative) @ $0	EDGAR
2022-05-27	4	Oesterle Stephen N. — Director	Grant/award (A): 8,888 (derivative) @ $0	EDGAR
2022-04-04	4	Yuan Qing Sarah — CTOO	Grant/award (A): 120,000 (derivative) @ $0	EDGAR
2022-02-22	4	Ashton-Rickardt Philip — CHIEF SCIENTIFIC OFFICER	Grant/award (A): 90,000 (derivative) @ $1.48	EDGAR
2022-02-22	4	Pontes Josias — ACTING CHIEF FINANCIAL OFFICE	Grant/award (A): 60,000 (derivative) @ $1.48	EDGAR
2022-02-22	4	Orfali May — CHIEF MEDICAL OFFICER	Grant/award (A): 10,000 (derivative) @ $1.48	EDGAR
2022-02-22	4	Vivaldi Coelho Rogerio — PRESIDENT AND CEO, Director	Grant/award (A): 230,000 (derivative) @ $1.48	EDGAR
2022-01-04	4	Pontes Josias — VP, HEAD OF FINANCE	Grant/award (A): 65,000 (derivative) @ $3.03	EDGAR
2022-01-04	4	Orfali May — CHIEF MEDICAL OFFICER	Grant/award (A): 10,000 (derivative) @ $3.03	EDGAR
2022-01-04	4	Ashton-Rickardt Philip — CHIEF SCIENTIFIC OFFICER	Grant/award (A): 90,000 (derivative) @ $3.03	EDGAR
2022-01-04	4	Vivaldi Coelho Rogerio — PRESIDENT AND CEO, Director	Grant/award (A): 400,000 (derivative) @ $3.03	EDGAR

Recent 8-K events — Sigilon Therapeutics, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

Filed	Form	Items reported	Source
2023-08-11	8-K	2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits	EDGAR
2023-06-29	8-K	1.01 — Entry into a Material Definitive Agreement 8.01 — Other Events 9.01 — Financial Statements and Exhibits	EDGAR
2023-05-22	8-K	1.02 — Termination of a Material Definitive Agreement 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits	EDGAR
2023-05-09	8-K	2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits	EDGAR
2023-03-14	8-K	2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits	EDGAR
2023-03-10	8-K	7.01 — Regulation FD Disclosure	EDGAR
2023-02-28	8-K	8.01 — Other Events	EDGAR
2023-02-13	8-K	5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers	EDGAR
2022-12-21	8-K	3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing	EDGAR
2022-11-10	8-K	2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits	EDGAR

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=SGTX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs